Bio-Techne Q4 adjusted EPS $0.49 vs $0.55 YoY; revenue $306.1M (+2%)

BIO-TECHNE Corp

2024-FY EPS reported $1.05 revenue$1,159,060,000

Q4 organic revenue up 1% to $306.1M; FY2024 organic revenue up 1% to $1.2B.
GAAP EPS $0.25 vs $0.47; adjusted EPS $0.49 vs $0.55.
Diagnostics & Genomics segment grew 9% organically in Q4.
FY2024 operating cash flow $299M, up 18% YoY.
Board declared $0.08 quarterly dividend payable Aug 30, record Aug 19.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.